Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
03/2012
03/22/2012DE102010045797A1 Verbindungen für die Diagnostik neurodegenerativer Erkrankungen am Riechepithel Compounds for the diagnosis of neurodegenerative diseases of the olfactory epithelium
03/22/2012CA2812088A1 Phtalazine derivatives as jak1 inhibitors
03/22/2012CA2812081A1 Triazine-oxadiazoles
03/22/2012CA2811080A1 Heterocyclic compound
03/21/2012EP2431370A1 Monoacylated 1,2-diaminocycloalkanes
03/21/2012EP2431362A1 3-(4-aminophenyl)-2-furancarboxylic acid derivative and pharmaceutically acceptable salt thereof
03/21/2012EP2431357A2 3-Aminopyrrolidine Derivatives as Modulators of Chemokine Receptors
03/21/2012EP2430019A1 Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene a4 hydrolase
03/21/2012EP2430014A1 Antiviral compounds
03/21/2012EP2430012A1 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof, and therapeutic use thereof
03/21/2012EP2430011A1 5-pyridin-3-yl-1,3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or cyp11b1
03/21/2012EP2430006A1 Cyclopenta[c]pyrrole-2-carboxylate derivatives, preparation thereof, and therapeutic use thereof
03/21/2012EP2430004A2 Novel oxazolidinone derivatives and their use as orexin receptor antagonists
03/21/2012EP2429993A1 Inhibitors of human immunodeficiency virus replication
03/21/2012EP2429523A1 Thiazolidin-4-one and [1,3]-thiazinan-4-one compounds as orexin receptor antagonists
03/21/2012EP2118093B1 [1,2,3]triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis
03/21/2012EP2078015B1 Modulators of glucocorticoid receptor, ap-1 and/or nf-kappab activity and use thereof
03/21/2012EP1996563B1 Heterobicyclic sulfonamide derivatives for the treatment of diabetes
03/21/2012EP1422218B1 Antiviral agent
03/21/2012CN102388040A Alkylamino-substituted dicyanopyridines and their amino acid ester prodrugs
03/21/2012CN102388032A Substituted piperidines as CCR3 antagonists
03/21/2012CN102388023A Organic compounds and their uses
03/21/2012CN102388022A Hydrazide compound and use of the same in pest control
03/21/2012CN102382108A Tetrazole compounds containing 1,2,3-bismuththiol methylene, preparation methods for same and application thereof
03/21/2012CN102379872A Compounds, compositions and methods of inhibiting a-synuclein toxicity
03/21/2012CN101747330B Pyridyl thiazole amines compound, as well as medical composite and application thereof
03/21/2012CN101687800B Glucokinase activator
03/21/2012CN101513402B Antiviral agent
03/21/2012CN101503398B Novel sulfide or sulfone containing dianhydride, and preparation and use thereof
03/21/2012CN101412712B Luminescent material naphtho oxazole derivative and preparation thereof
03/21/2012CN101298427B Diaryl urea compound and use thereof
03/21/2012CN101258147B Derivatives of 4-piperazin-1-yl-4-benz0[B]thiophene suitable for the treatment of CNS disorders
03/21/2012CN101035795B Thiazolyl-dihydro indazoles
03/20/2012US8138348 Methods for oligomerizing olefins with chromium pyridine mono-oxazoline catalysts
03/20/2012US8138336 Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
03/20/2012US8138213 Isoxazoline-substituted benzamide compound and pesticide
03/20/2012US8138185 Urea glucokinase activators
03/20/2012US8138182 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
03/20/2012CA2553423C Heterocyclic compounds for use in the treatment of cancer and the inhibition of angiogenesis
03/20/2012CA2526026C Furazanobenzimidazoles
03/20/2012CA2505029C Isoindoline derivatives
03/20/2012CA2493225C Quinoline derivatives and their use as mycobacterial inhibitors
03/20/2012CA2472711C 2-acylaminothiazole derivative or salt thereof
03/20/2012CA2396227C 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation
03/15/2012WO2012033993A2 Methods for assaying enzyme activities
03/15/2012WO2012033736A1 Novel piperazine analogs as broad-spectrum influenza antivirals
03/15/2012WO2012033548A2 Herbicidal bis-nitrogen-containing oxo and sulfono heterocycles
03/15/2012WO2012033195A1 Heterocyclic compound
03/15/2012WO2012033069A1 Prostaglandin d synthase inhibitory piperidine compounds
03/15/2012WO2012031941A2 2-(R²-THIO)-10-[3-(4-R1-PIPERAZIN-1-YL)PROPYL]-10H-PHENOTHIAZINE FOR TREATING A β-AMYLOIDOPATHY OR AN ALPHA-SYNUCLEOPATHY, AND METHOD FOR THE DIAGNOSIS OR PREDIAGNOSIS THEREOF
03/15/2012WO2012007555A3 New ziprasidone salts and methods of their formation
03/15/2012WO2011147951A8 Cycloamino derivatives as gpr119 agonists
03/15/2012WO2011139886A3 Preparation of febuxostat
03/15/2012WO2011131748A3 Benzimidazole derivatives as inhibitors of glutaminyl cyclase
03/15/2012US20120065403 Benzothiazole Derivatives
03/15/2012US20120065213 C-met protein kinase inhibitors
03/15/2012US20120065212 Heteroarylmethyl amides
03/15/2012US20120065203 Methods of Reducing Serum Glucose and Triglyceride Levels and for Inhibiting Angiogenesis Using Substituted Indolealkanoic Acids
03/15/2012US20120065196 Amide compounds
03/15/2012US20120065195 Compounds for treating neurodegenerative diseases
03/15/2012US20120065185 Substituted alkylamine derivatives and methods of use
03/15/2012US20120064181 P2X3 Receptor Antagonists for Treatment of Pain
03/15/2012US20120064121 Pyridine compounds for inflammation and immune-related uses
03/15/2012US20120064032 Novel hydroxamates as therapeutic agents
03/15/2012CA2811454A1 2-(r2-thio)-10-[3-(4-r1-piperazin-1-yl)propyl]-10h-phenothiazine for treating a b-amyloidopathy or an alpha-synucleopathy, and method for the diagnosis or prediagnosis thereof
03/15/2012CA2810489A1 Prostaglandin d synthase inhibitory piperidine compounds
03/15/2012CA2809624A1 Novel piperazine analogs as broad-spectrum influenza antivirals
03/14/2012EP2428586A1 Dimeric and trimeric nucleic acid dyes, and associated systems and methods
03/14/2012EP2428508A1 Diamino heterocyclic carboxamide compound
03/14/2012EP2428507A2 Cannabinoid receptor ligands
03/14/2012EP2427459A1 Isoxazole-thiazole derivatives as gaba a receptor inverse agonists for use in the treatment of cognitive disorders
03/14/2012EP2427456A1 Isoxazole-pyridine derivatives
03/14/2012EP2427453A1 Novel substituted indazole and aza-indazole derivatives as gamma secretase modulators
03/14/2012EP2427452A1 P38 kinase inhibiting agents
03/14/2012EP2427447A2 Small molecule inhibitors of influenza a and b virus and respiratory syncytial virus replication
03/14/2012EP2427442A1 2,1,3-benzoxadiazol derivatives for the inhibition of influenza a and b virus and respiratory syncytial virus replication
03/14/2012EP2427441A1 Pmk2 modulators for use in the treatment of cancer
03/14/2012EP2427437A1 Dihydropyrimidinones for use as bace2 inhibitors
03/14/2012EP2427436A1 Substituted aromatic carboxamide and urea derivatives as vanilloid receptor ligands
03/14/2012EP2427434A1 Process for preparing bromo-substituted quinolines
03/14/2012EP2427194A1 Pyrrolidine-derived beta 3 adrenergic receptor agonists
03/14/2012EP2427191A1 Pesticidal compositions
03/14/2012EP2284169B1 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of CNS disorders
03/14/2012EP2240474B1 Cyclic pyridyl-n-(1,3,4)-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
03/14/2012EP2064196B1 3-amino-1,2-benzisothiazole compounds for combating animal pest ii
03/14/2012EP1971603B1 SULFOXIMINE DERIVATIVES AS p38 MAP KINASE INHIBITORS
03/14/2012EP1948627B1 Novel dual peptidase inhibitors as prodrugs for the therapy of inflammatory and other disorders
03/14/2012EP1928872B1 Novel sulphonylpyrroles as inhibitors of hdac
03/14/2012EP1667685B1 Quinazoline potassium channel inhibitors
03/14/2012EP1147104B1 Aromatic heterocyclic compounds as antiinflammatory agents
03/14/2012CN102372705A Salt of proline derivative, solvate thereof, and production method thereof
03/14/2012CN102372704A Salt of proline derivative, solvate thereof, and production method thereof
03/14/2012CN102372703A Indole benzothiazole derivative and pharmaceutical use thereof
03/14/2012CN102372702A Preparation method for thiamethoxam
03/14/2012CN102372701A Azabicyclo hexane derivative, preparation method, and application of azabicyclo hexane derivative in medicine
03/14/2012CN102372692A Dihydropyridine derivative
03/14/2012CN102372681A Environment-friendly thiazole compound as well as preparation and application thereof
03/14/2012CN101575336B N-aryl piperazine derivative and preparation method thereof and drug composition adopting N-aryl piperazine derivative as active ingredient
03/14/2012CN101484448B Pyrazole alkanamide substituted thiophenes as AMPA potentiators
03/13/2012US8133995 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
1 ... 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 ... 628